ThymuSkin Clinical
Studies
|
ThymuSkin Hair
Treatment should be an important part of your hair care routine. It
guards against hair loss and dandruff, and activates new hair growth.
Price approx C$108/£45 |
ThymuSkin |
FAQ
ThymuSkin
® Clinical Studies
ThymuSkin® is a topical hair
treatment.
Over
ten years of clinical studies have been performed on the use of
ThymuSkin® as an effective treatment of alopecia androgenetica
(Pattern Baldness), diffusa (Hair Loss Over The Whole Scalp and Possible
All Parts Of The Body), and areate (Patchy Bladness). The hair shampoo,
treatment (revitalizer) and hair rinse are cosmetics containing thymus
gland extract, plant proteins, methyl glucose, elastin, avocado oil,
citric acid, pyridoxine, linolic acid, tocopherol acetate, retinyl
palmitate, demineralized water, additives and preservatives.
The use of
ThymuSkin® in conjunction with chemotherapeutical treatments, has
been shown to reduce or completely eliminate associated incidences of
alopecia totalis. The mitigation of alopecia totalis reduces
psychological stress on the patient, which can increase the overall
effectiveness of treatment.
ThymuSkin®
has been shown to be effective in reducing hair loss and creating new
hair growth in individuals who experience alopecia androgenetica
(Pattern Baldness) and alopecia areata.
Of particular
interest is the documentation of no side effects in conjunction with the
use of ThymuSkin®. The explanation of the mode of action of
ThymuSkin® is a subject of various clinical trials still on-going.
The development of
ThymuSkin® could not have occurred without the support of
Physicians of the Universities of Heidelberg, Munster- Osnabruck,
Hannover and Munich.
Additional
research has been provided from the Ludwig-Boltzmann Institute in
Darmstadt. Scientific support continues by the German Cancer Research
Center (DKFZ), Heidelberg and the Ministry of Science and Technology in
Bonn-Bad, Godesberg.
Summary Of The Clinical Effects of ThymuSkin®
The
following table presents a comparison of treatment regimes and their
effectiveness for the treatment of Alopecia.
|
Therapy
|
Alopecia
Types of Baldness
|
Sex of
Patients
|
Duration of
Therapy
|
Therapy Success (%)
|
Author Year
|
|
ThymuSkin®
|
androgenetica
(Pattern Baldness)
|
Women
|
12
|
100
|
Mössler
/91
|
|
ThymuSkin®
|
androgenetica
(Pattern Baldness)
|
Men
|
12
|
67
|
|
|
ThymuSkin®
|
areata
|
Women
|
12
|
86
|
|
|
ThymuSkin®
|
areata
|
Men
|
12
|
86
|
|
|
ThymuSkin®
|
areata totalis
universalis
|
Both Sexes
|
9-24
|
65
|
|
|
ThymuSkin®
|
diffusa
|
Women
|
12
|
87
|
Klobusch /90
|
|
ThymuSkin®
|
chemotherapy
|
Both Sexes
|
6
|
32-93
|
Lupke
/90
|
|
ThymuSkin®
|
diffusa
|
Women
|
6
|
73
|
Mössler et
al/87
|
University
Women's Hospital/Heidelberg
Clinical Effects of ThymuSkin®
Clinically
tested in Europe for over 10 years.
ThymuSkin®
strengthens the inner structure of hair.
ThymuSkin®
Hair Treatment shows positive effects on hair growth in patients with
all types of alopecia.
By reactivating
and rejuvenating the hair follicles ThymuSkin® leads to new
hair growth in men, women and children.
Patients and
Customers are confirming the positive effects of ThymuSkin®
world wide.
Clinically Documented Effects of
ThymuSkin® on Hair-Loss
Information
presented in this overview is the result of clinical investigations on
the product - ThymuSkin®. These findings are produced in
collaboration with the following investigators:
Vienna City
Hospital - Austria
Dept. of Surgery
Ludwig Boltzmann Institute for
Clinical Oncology
Prof. Dr. H. Denck, M.D.
Municipal Clinics
of Darmstadt
University of Frankfurt
Dermatology Clinic - Director
Prof. Dr. Hagedorn, M.D.
Ruprecht - Karls
University of Heidelberg
Gynecological Clinic
Prof. Dr. H.C.V Runnebaum M.D.
(Honorary)
University Clinic
of Meunster
Oncology / Surgery
Dr. H. Wilke, M.D.
Medical Clinic of
the University of
Munich
Dept of Hematology/Oncology
Prof. Dr. Claus O. Kohler
Medical University
of Hannover
Dept. of Hematology/Oncology
Dr. H. Wilke, M.D.
University of
Osnabrueck, Germany
Chairman of the Division of Pharmacology and Toxicology
Prof. Dr. med. Niels Peter Lüpke M.D.
Hospital of
Darmstadt, Germany
Dermatology Clinic
Prof. Dr. Claus O. Köhler M.D.
|
